0001396677-12-000049.txt : 20121217
0001396677-12-000049.hdr.sgml : 20121217
20121217171652
ACCESSION NUMBER: 0001396677-12-000049
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121213
FILED AS OF DATE: 20121217
DATE AS OF CHANGE: 20121217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HUME GARY M
CENTRAL INDEX KEY: 0001265853
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23731
FILM NUMBER: 121269338
MAIL ADDRESS:
STREET 1: C/O NUTRACEUTICAL INTERNATIONAL CORP
STREET 2: 1400 KEARNS BLVD 2ND FL.
CITY: PARK CITY
STATE: UT
ZIP: 84060
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NUTRACEUTICAL INTERNATIONAL CORP
CENTRAL INDEX KEY: 0001050007
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 870515089
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 1400 KEARNS BOULEVARD
STREET 2: 2ND FLOOR
CITY: PARK CITY
STATE: UT
ZIP: 84060
BUSINESS PHONE: 4356556000
MAIL ADDRESS:
STREET 1: 1400 KEARNS BOULEVARD
STREET 2: 2ND FLOOR
CITY: PARK CITY
STATE: UT
ZIP: 84060
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2012-12-13
0
0001050007
NUTRACEUTICAL INTERNATIONAL CORP
NUTR
0001265853
HUME GARY M
C/O NUTRACEUTICAL INTERNATIONAL CORP
1400 KEARNS BLVD 2ND FL.
PARK CITY
UT
84060
0
1
0
0
Executive Vice President
Common Stock
2012-12-13
4
M
0
5000
12.32
A
8635.433
D
Common Stock
2012-12-13
4
S
0
5000
16.6432
D
3635.433
D
Common Stock
2012-12-14
4
M
0
3000
12.32
A
6635.433
D
Common Stock
2012-12-14
4
S
0
3000
16.635
D
3635.433
D
Employee Stock Option (right to buy)
12.32
2012-12-13
4
M
0
5000
0
D
2013-12-17
Common Stock
5000
5000
D
Employee Stock Option (right to buy)
12.32
2012-12-14
4
M
0
3000
0
D
2013-12-17
Common Stock
3000
2000
D
The price shown in Column 4 is a weighted average sale price. The price range for the sales is $16.52 to $16.75. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The price shown in Column 4 is a weighted average sale price. The price range for the sales is $16.60 to $16.73. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The option vested in six equal installments every six months beginning on June 17, 2004.
/s/ Alison Pitt, attorney in fact
2012-12-17